Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD

Overview of attention for article published in BMC Pulmonary Medicine, July 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,405 followers.

Abediterol, un nuevo B2 con acción BD más intensa que indacaterol https://t.co/NF1ZjAAYi7 #bmcpulmmed

Reply Repost Favourite

Abediterol, a novel long-acting β2-agonist: bronchodilation, safety… https://t.co/MTiGsbn1oW #eprompt #respire

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.